U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C92H150N22O25
Molecular Weight 1964.3078
Optical Activity UNSPECIFIED
Defined Stereocenters 12 / 12
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ALAMETHICIN

SMILES

CC(C)C[C@@H](NC(=O)CNC(=O)C(C)(C)NC(=O)[C@@H](NC(=O)C(C)(C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)C(C)(C)NC(=O)[C@H](C)NC(=O)C(C)(C)NC(=O)[C@@H]1CCCN1C(=O)C(C)(C)NC(C)=O)C(C)C)C(=O)NC(C)(C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(C)C)C(=O)NC(C)(C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@](C)(CCC(N)=O)C(=O)N[C@H](CO)CC3=CC=CC=C3

InChI

InChIKey=NRRXBXXRKXUIFD-ZTEFGAJGSA-N
InChI=1S/C92H150N22O25/c1-47(2)43-58(72(127)108-91(23,24)84(139)113-41-29-33-59(113)73(128)103-65(48(3)4)75(130)111-88(17,18)80(135)97-51(8)68(123)102-57(36-38-64(120)121)71(126)112-92(25,40-39-62(94)118)82(137)99-55(46-115)44-54-31-27-26-28-32-54)100-63(119)45-95-77(132)85(11,12)110-76(131)66(49(5)6)104-81(136)89(19,20)107-70(125)56(35-37-61(93)117)101-67(122)50(7)96-78(133)86(13,14)106-69(124)52(9)98-79(134)87(15,16)109-74(129)60-34-30-42-114(60)83(138)90(21,22)105-53(10)116/h26-28,31-32,47-52,55-60,65-66,115H,29-30,33-46H2,1-25H3,(H2,93,117)(H2,94,118)(H,95,132)(H,96,133)(H,97,135)(H,98,134)(H,99,137)(H,100,119)(H,101,122)(H,102,123)(H,103,128)(H,104,136)(H,105,116)(H,106,124)(H,107,125)(H,108,127)(H,109,129)(H,110,131)(H,111,130)(H,112,126)(H,120,121)/t50-,51-,52-,55-,56-,57-,58+,59-,60-,65-,66-,92-/m0/s1

HIDE SMILES / InChI

Molecular Formula C92H150N22O25
Molecular Weight 1964.3078
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 12 / 12
E/Z Centers 11
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Detection of new amino acid sequences of alamethicins F30 by nonaqueous capillary electrophoresis-mass spectrometry.
2006-04
Many-body effect of antimicrobial peptides: on the correlation between lipid's spontaneous curvature and pore formation.
2005-12
Biotransformation of a GABAA receptor partial agonist in sprague-dawley rats and cynomolgus monkeys: identification of two unique N-carbamoyl metabolites.
2005-11
Rapid collapse of mitochondrial transmembrane potential in HL-60 cells and isolated mitochondria treated with anti-tumor 1,4-anthracenediones.
2005-10
Interaction of alamethicin with ether-linked phospholipid bilayers: oriented circular dichroism, 31P solid-state NMR, and differential scanning calorimetry studies.
2005-10
Alamethicin permeabilizes the plasma membrane and mitochondria but not the tonoplast in tobacco (Nicotiana tabacum L. cv Bright Yellow) suspension cells.
2005-08-01
Activation of calcium-independent phospholipase A (iPLA) in brain mitochondria and release of apoptogenic factors by BAX and truncated BID.
2005-08
Comparative kinetic analysis reveals that inducer-specific ion release precedes the mitochondrial permeability transition.
2005-07-15
Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT1.
2005-06-03
Impact of end-product inhibition on the determination of in vitro metabolic clearance.
2005-05
Ca2+-induced permeabilization promotes free radical release from rat brain mitochondria with partially inhibited complex I.
2005-05
Colloidal quantum dots initiating current bursts in lipid bilayers.
2005-04-15
Na,K-ATPase reconstituted in liposomes: effects of lipid composition on hydrolytic activity and enzyme orientation.
2005-04-10
A historical overview of the heterologous expression of mammalian UDP-glucuronosyltransferase isoforms over the past twenty years.
2005-04
Possible involvement of glutamic and/or aspartic acid residue(s) and requirement of mitochondrial integrity for the protective effect of creatine against inhibition of cardiac mitochondrial respiration by methylglyoxal.
2005-03
Cellular and subcellular calcium accumulation during glutamate-induced injury in cerebellar granule neurons.
2005-03
Zinc ions as cytochrome C oxidase inhibitors: two sites of action.
2005-02
Calcium-dependent dephosphorylation of brain mitochondrial calcium/cAMP response element binding protein (CREB).
2005-01
In vitro studies in microsomes from rat and human liver, kidney, and intestine suggest that perfluorooctanoic acid is not a substrate for microsomal UDP-glucuronosyltransferases.
2005
Peptaibols and related peptaibiotics of Trichoderma. A review.
2005
Ca2+-induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms: role of cardiolipin.
2004-12-17
Microscopic visualization of alamethicin incorporation into model membrane monolayers.
2004-12-07
The human TAZ gene complements mitochondrial dysfunction in the yeast taz1Delta mutant. Implications for Barth syndrome.
2004-10-22
High-performance liquid chromatography-based methods of enzymatic analysis: electron transport chain activity in mitochondria from human skeletal muscle.
2004-10-01
Conductance studies on trichotoxin_A50E and implications for channel structure.
2004-09
Herbivore-induced defense response in a model legume. Two-spotted spider mites induce emission of (E)-beta-ocimene and transcript accumulation of (E)-beta-ocimene synthase in Lotus japonicus.
2004-08
Conformation of peptides in lipid membranes studied by x-ray grazing incidence scattering.
2004-07
Absence of NADH channeling in coupled reaction of mitochondrial malate dehydrogenase and complex I in alamethicin-permeabilized rat liver mitochondria.
2004-06-11
Peptaibol zervamicin IIb structure and dynamics refinement from transhydrogen bond J couplings.
2004-06
Oxidation and reduction of pyridine nucleotides in alamethicin-permeabilized plant mitochondria.
2004-05-15
Helical kink and channel behaviour: a comparative study with the peptaibols alamethicin, trichotoxin and antiamoebin.
2004-05
Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I.
2004-04-23
Quantitative evaluation of the effects of mitochondrial permeability transition pore modifiers on accumulation of calcium phosphate: comparison of rat liver and brain mitochondria.
2004-04-01
Energetics of pore formation induced by membrane active peptides.
2004-03-30
Engineering charge selectivity in model ion channels.
2004-03-15
Real-time flow cytometry analysis of permeability transition in isolated mitochondria.
2004-03-10
Highly robust lipid membranes on crystalline S-layer supports investigated by electrochemical impedance spectroscopy.
2004-03-09
Impedance analysis and single-channel recordings on nano-black lipid membranes based on porous alumina.
2004-02
Implicit solvent model estimates of the stability of model structures of the alamethicin channel.
2004-02
Conformational changes in alamethicin associated with substitution of its alpha-methylalanines with leucines: a FTIR spectroscopic analysis and correlation with channel kinetics.
2004-01
Total synthesis in solution of alamethicin F50/5 by an easily tunable segment condensation approach.
2004
Sequences of alamethicins F30 and F50 reconsidered and reconciled.
2003-12-09
Template-free self-assembling fullerene and lipopeptide conjugates of alamethicin form voltage-dependent ion channels of remarkable stability and activity.
2003-12-09
Channel properties of template assembled alamethicin tetramers.
2003-12-09
Interactions of the M2delta segment of the acetylcholine receptor with lipid bilayers: a continuum-solvent model study.
2003-12
An Arabidopsis thaliana gene for methylsalicylate biosynthesis, identified by a biochemical genomics approach, has a role in defense.
2003-12
The antibacterial peptide ceratotoxin A displays alamethicin-like behavior in lipid bilayers.
2003-11
Metabolic assessment in liver microsomes by co-activating cytochrome P450s and UDP-glycosyltransferases.
2003-10-07
Microfabricated teflon membranes for low-noise recordings of ion channels in planar lipid bilayers.
2003-10
Mechanosensing and signal transduction in tendrils.
2003
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:59:12 GMT 2025
Edited
by admin
on Mon Mar 31 21:59:12 GMT 2025
Record UNII
0LT1I1B7S8
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AC-AIB-PRO-AIB-ALA-AIB-ALA-GLN-AIB-VAL-AIB-GLY-LEU-AIB-PRO-VAL-AIB-AIB-GLU-GLN-PHL
Preferred Name English
ALAMETHICIN
Common Name English
Code System Code Type Description
CAS
27061-78-5
Created by admin on Mon Mar 31 21:59:12 GMT 2025 , Edited by admin on Mon Mar 31 21:59:12 GMT 2025
PRIMARY
EPA CompTox
DTXSID40893675
Created by admin on Mon Mar 31 21:59:12 GMT 2025 , Edited by admin on Mon Mar 31 21:59:12 GMT 2025
PRIMARY
FDA UNII
0LT1I1B7S8
Created by admin on Mon Mar 31 21:59:12 GMT 2025 , Edited by admin on Mon Mar 31 21:59:12 GMT 2025
PRIMARY
PUBCHEM
76958618
Created by admin on Mon Mar 31 21:59:12 GMT 2025 , Edited by admin on Mon Mar 31 21:59:12 GMT 2025
PRIMARY
WIKIPEDIA
ALAMETHICIN
Created by admin on Mon Mar 31 21:59:12 GMT 2025 , Edited by admin on Mon Mar 31 21:59:12 GMT 2025
PRIMARY